Skip to main content

Peer Review reports

From: Understanding medicine access strategies for innovator medicines registered in South Africa

Original Submission
30 May 2024 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
6 Jun 2024 Author responded Author comments - Thulasizwe Njabulo Qiniso Jama
Resubmission - Version 4
6 Jun 2024 Submitted Manuscript version 4
7 Jun 2024 Author responded Author comments - Thulasizwe Njabulo Qiniso Jama
Resubmission - Version 5
7 Jun 2024 Submitted Manuscript version 5
24 Jun 2024 Reviewed Reviewer Report - Babafunso A Adenuga
4 Jul 2024 Reviewed Reviewer Report
25 Jul 2024 Reviewed Reviewer Report - Titilayo O. Fakeye
7 Aug 2024 Author responded Author comments - Thulasizwe Njabulo Qiniso Jama
Resubmission - Version 6
7 Aug 2024 Submitted Manuscript version 6
8 Aug 2024 Author responded Author comments - Thulasizwe Njabulo Qiniso Jama
Resubmission - Version 7
8 Aug 2024 Submitted Manuscript version 7
14 Sep 2024 Reviewed Reviewer Report - Babafunso A Adenuga
25 Sep 2024 Author responded Author comments - Thulasizwe Njabulo Qiniso Jama
Resubmission - Version 8
25 Sep 2024 Submitted Manuscript version 8
2 Oct 2024 Author responded Author comments - Thulasizwe Njabulo Qiniso Jama
Resubmission - Version 9
2 Oct 2024 Submitted Manuscript version 9
Publishing
3 Oct 2024 Editorially accepted
11 Oct 2024 Article published 10.1186/s12913-024-11696-4

You can find further information about peer review here.

Back to article page